Home

Rare Gynaecological Cancers Are Common

Approximately 18.5 million women annually are affected by gynaecological cancer, of which around 50% are classified as rare cancers.

Read More

Delayed Diagnosis Leads to Poor Outcome

Delayed diagnosis of patients suffering from rare gynaecological cancers leads to poor outcomes and contributes to a huge socio-economic burden.

Read More

Our Mission

GYNOCARE aims to create a unique network between key stakeholders covering five distinct domains (from concept to cure): basic research on rare gynaecological cancer, biobanking, industrial dimension, legal and regulatory requirements for international trials and other research collaborative efforts, and high-quality, international, and innovative clinical trials. To achieve our ambitious goals, we have devised research coordination and capacity building objectives in accordance with mission and vision of the COST Action.

GYNOCARE will focus on (1) capacity-building on rare gynaecological cancer by connecting high-quality scientific communities in various disciplines, existing networks, policy-makers, industrial partners, and patient organisations across Europe and beyond; (2) coordinating, and contributing to the development of a research roadmap dedicated to connect innovative basic research to harmonised biobanking to ‘smarter’ clinical trials; (3) developing a platform for sharing best practices, including funding roadmap and legal/ethical requirements, in gynaecological cancers, aiming to advice policy-makers and other key stakeholders;  and (4) providing equal networking opportunities for early-stage researchers, and other talented young professionals.

Main Contacts

Prof Jean Calleja-Agius

Action Chair

University of Malta,

Malta

jean.calleja-agius@um.edu.mt

Dr Vera Dimitrievska

Science Communication Manager

American College,

North Macedonia

vdimitrievska@gmail.com

Prof David Faraggi

Action Vice Chair

University of Haifa,

Israel

dfaraggi@univ.haifa.ac.il

Dr Maria Santos

STSM Coordinator

Universidade de Lisboa,

Portugal

mariasantos@ff.ulisboa.pt

Dr Federica Ortelli

Science Officer

COST Association,

Brussels

federica.ortelli@cost.eu

Dr Riccardo Di Fiore

ITC Conference Manager

University of Malta,

Malta

riccardo.difiore@um.edu.mt

Ms Aldona Gembalik

Administrative Officer

COST Association,

Brussels

aldona.gembalik@cost.eu

Ms Diandra Borg-Meli

Grants Manager

University of Malta,

Malta

diandra.meli@um.edu.mt

Latest News

New publication on Cervical Cancer Stem Cells

11 May 2022 1:51 PM

The potential of therapeutic targeting of CCSCs

World Ovarian Cancer Day

08 May 2022 10:45 PM

Commemorated on the 8th May 2022

STSM at TU Delft

18 April 2022 8:01 PM

First STSM awarded

Conference & MC meeting in Malta

18 April 2022 7:17 PM

Save the dates 23 & 24 May 2022

New Call for Short Term Scientific Missions

27 March 2022 1:58 PM

STSMs in 2022

New Call for Virtual Mobility Grants in 2022

25 March 2022 12:27 PM

Brief Report on Gonadoblastoma

03 March 2022 12:20 PM

Gonadoblastoma is a rare type of tumour which can occur…

A case of Epithelioid Trophoblastic Tumour

10 December 2021 11:12 AM

Genetic Linkage to a Child Born over Seventeen Years Prior,…

New Publication on the Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers

06 November 2021 5:47 AM

Croatian MC GYNOCARE COST members publish collaborative review article

Review article on the Role of Omics in Rare Ovarian Cancers

09 October 2021 11:21 AM

Norwegian MC GYNOCARE COST member publishes new collaborative article

Virtual Mobility Grants

30 August 2021 4:45 PM

Six new Virtual Mobility grants are now available.

New Publication: Link between LncRNA MORT (ZNF667-AS1) and Gynaecological Cancer

22 July 2021 1:22 PM

Long non‑coding RNAs (lncRNAs) play a critical role in tumorigenesis.…

18.5

million gynae cancer patients

50%

rare gynae cancers

30

countries

70+

professionals

Latest Events

Kick Off Meeting

26th October 2020 00:00 AM

Scientific Session of the 6th Annual Malta Rare Disease Colloquium

28th May 2021 14:00 PM

The Scientific Session of 6th Annual Malta Rare Disease Colloquium was held on…

27th European Congress of Obstetrics and Gynaecology

2nd September 2021 00:00 AM

Oral presentation on GYNOCARE COST Action

Kick Off Meeting

26th October 2020 00:00 AM

Scientific Session of the 6th Annual Malta Rare Disease Colloquium

28th May 2021 14:00 PM

The Scientific Session of 6th Annual Malta Rare Disease Colloquium was held on…

27th European Congress of Obstetrics and Gynaecology

2nd September 2021 00:00 AM

Oral presentation on GYNOCARE COST Action

Kick-off Meeting under newly appointed Action Chairperson

Online meeting held on the 26th October 2020 10:00-12:00hrs

Our Work

Funding available for collaborative open access publications 

Five working groups covering the field of rare gynae cancer: from concept to cure

Patients

Open invitation to representatives of patient support groups 

Clinical Trials

Opportunities for collaboration in innovative multicentre clinical trials

Opportunities for short term scientific missions between COST countries

Legal and ethical requirements for improved  harmonisation of biobanking 

Treatment

Transfer of novel technologies to enhance personalised precision medicine